Avalo Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:C6K0 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
13 Nov 24	Buy€12,056	June Almenoff	Individual		1,000	€12.29

Insider Buying: C6K0 insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1205.3%.

Top 25 shareholders own 79.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.9%	BVF Partners L.P.	1,905,511	€17.2m	0%	0.55%
14.3%	OrbiMed Advisors LLC	1,611,667	€14.6m	0%	0.21%
8.63%	Ikarian Capital, LLC	970,359	€8.8m	1,670%	2.69%
8.6%	RA Capital Management, L.P.	967,000	€8.8m	0%	0.12%
8.6%	Deep Track Capital, LP	967,000	€8.8m	757%	0.29%
4.89%	Patrick Crutcher	549,467	€5.0m	96,600%	no data
4.79%	Logos Global Management, L.P.	539,079	€4.9m	0%	0.62%
4.3%	Commodore Capital LP	483,000	€4.4m	1,110%	0.32%
4.3%	TCG Crossover Management, LLC	483,000	€4.4m	0%	0.41%
1.46%	Boothbay Fund Management, LLC	164,092	€1.5m	1,380%	0.05%
0.7%	Allostery Investments LP	78,255	€708.4k	0%	100.0%
0.64%	Sio Capital Management, LLC	71,458	€646.8k	0%	0.33%
0.52%	Emerald Bioventures, Llc	58,346	€528.2k	0%	no data
0.4%	Affinity Asset Advisors, LLC	45,000	€407.3k	0%	0.08%
0.37%	Nantahala Capital Management, LLC	42,100	€381.1k	0%	0.03%
0.092%	The Vanguard Group, Inc.	10,368	€93.8k	0%	no data
0.09%	Geode Capital Management, LLC	10,111	€91.5k	1,720%	no data
0.055%	UBS Asset Management AG	6,134	€55.5k	71.2%	no data
0.05%	Bank of America Corporation, Asset Management Arm	5,601	€50.7k	0%	no data
0.0089%	June Almenoff	1,000	€9.0k	0%	no data
0.0033%	Tower Research Capital Europe Limited	376	€3.4k	0%	no data
0.0029%	BlackRock, Inc.	329	€3.0k	0%	no data
0.0017%	Lord, Abbett & Co. LLC	191	€1.7k	0%	no data
0.0013%	Steven Boyd	143	€1.3k	0%	no data
0.00053%	Garry Neil	60	€539.5	0%	no data